Search Saint Luke's

Saint Luke’s High-risk Breast Clinic delivers supplemental services for individuals who are at heightened risk for breast cancer. Through collaboration with the Hereditary Cancer Program at Saint Luke’s Cancer Institute, patients will meet with a genetic counselor to evaluate family history in identifying genetic risk factors.

Colorectal Cancer

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Lung Cancer

A081801 Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO

Breast Cancer 

De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

Lung Cancer

A Multicenter Randomized Trial of EBUS-TBNA Versus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing

Breast Cancer | Solid Tumors
Phase 1a/1b Study of the PI3Kα:RAS Breaker BBO-10203 in Subjects with Advanced Solid Tumors (The BREAKER-101 Trial)

Pancreatic Cancer

RASolute 304: A Phase 3 Multicenter, Open-label, Randomized, 2-Arm Study of Adjuvant Daraxonrasib versus Observation Following Curative Intent Therapy in Patients with Resected Pancreatic Ductal Adenocarcinoma (PDAC)